News Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
42.2 ^TWD	+2.30%		+3.43%	+8.48%

Apr. 05	Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	CI
Mar. 29	Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	Apr. 04	CI
Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	Mar. 28	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Accounting Officer	23-08-10	CI
Orient EuroPharma Co., Ltd. Appoints Jack Wang as Financial Officer	23-08-01	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Orient EuroPharma, OncoVent Sign License Deal	23-03-30	MT
OncoVent Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab	23-03-28	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-06	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

Summary

Filters